|
1.
|
Tseng CH: Oral cancer in Taiwan: is
diabetes a risk factor? Clin Oral Investig. Aug 16–2012.(Epub ahead
of print).
|
|
2.
|
Bau DT, Tseng HC, Wang CH, et al: Oral
cancer and genetic polymorphism of DNA double strand break gene
Ku70 in Taiwan. Oral Oncol. 44:1047–1051. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Chie WC, Li CY, Huang CS, Chang KJ, Yen ML
and Lin RS: Oral contraceptives and breast cancer risk in Taiwan, a
country of low incidence of breast cancer and low use of oral
contraceptives. Int J Cancer. 77:219–223. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Zavras AI, Douglass CW, Joshipura K, et
al: Smoking and alcohol in the etiology of oral cancer:
gender-specific risk profiles in the south of Greece. Oral Oncol.
37:28–35. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Moreno-Lopez LA, Esparza-Gomez GC,
Gonzalez-Navarro A, Cerero-Lapiedra R, Gonzalez-Hernandez MJ and
Dominguez-Rojas V: Risk of oral cancer associated with tobacco
smoking, alcohol consumption and oral hygiene: a case-control study
in Madrid, Spain. Oral Oncol. 36:170–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Kerawala CJ: Oral cancer, smoking and
alcohol: the patients’ perspective. Br J Oral Maxillofac Surg.
37:374–376. 1999.
|
|
7.
|
Shukla D, Dinesh Kale A, Hallikerimath S,
Vivekanandhan S and Venkatakanthaiah Y: Genetic polymorphism of
drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for
oral premalignant lesions and oral cancer. Biomed Pap Med Fac Univ
Palacky Olomouc Czech Repub. 156:253–259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Plu-Bureau G, Bossard N and Thalabard JC:
Oral contraception and genetic factors in breast cancer:
characteristics and limits of case-only studies. Rev Epidemiol
Sante Publique. 48:294–303. 2000.(In French).
|
|
9.
|
Hung HC, Chuang J, Chien YC, et al:
Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental
factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev.
6:901–905. 1997.PubMed/NCBI
|
|
10.
|
Yang YY, Koh LW, Tsai JH, et al:
Involvement of viral and chemical factors with oral cancer in
Taiwan. Jpn J Clin Oncol. 34:176–183. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Jung J, Cho NH, Kim J, et al: Significant
invasion depth of early oral tongue cancer originated from the
lateral border to predict regional metastases and prognosis. Int J
Oral Maxillofac Surg. 38:653–660. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Hour MJ, Lee KT, Wu YC, et al: A novel
antitubulin agent, DPQZ, induces cell apoptosis in human oral
cancer cells through Ras/Raf inhibition and MAP kinases activation.
Arch Toxicol. Dec 5–2012.(Epub ahead of print).
|
|
13.
|
Shin JA, Kim JS, Hong IS and Cho SD: Bak
is a key molecule in apoptosis induced by methanol extracts of
Codonopsis lanceolata and Tricholoma matsutake in
HSC-2 human oral cancer cells. Oncol Lett. 4:1379–1383.
2012.PubMed/NCBI
|
|
14.
|
Tsai SC, Lu CC, Lee CY, et al: AKT
serine/threonine protein kinase modulates bufalin-triggered
intrinsic pathway of apoptosis in CAL 27 human oral cancer cells.
Int J Oncol. 41:1683–1692. 2012.PubMed/NCBI
|
|
15.
|
Xu XH, Gan YC, Xu GB, et al: Tetrandrine
citrate eliminates imatinib-resistant chronic myeloid leukemia
cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis. J
Zhejiang Univ Sci B. 13:867–874. 2012.PubMed/NCBI
|
|
16.
|
Gao S, Cui YL, Yu CQ, Wang QS and Zhang Y:
Tetrandrine exerts antidepressant-like effects in animal models:
role of brain-derived neurotrophic factor. Behav Brain Res.
238:79–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Gong K, Chen C, Zhan Y, Chen Y, Huang Z
and Li W: Autophagy-related gene 7 (ATG7) and reactive oxygen
species/extracellular signal-regulated kinase regulate
tetrandrine-induced autophagy in human hepatocellular carcinoma. J
Biol Chem. 287:35576–35588. 2012. View Article : Google Scholar
|
|
18.
|
Shan QQ, Gong YP, Guo Y, Lin J, Zhou RQ
and Yang X: Anti-tumor effect of tanshinone II A, tetrandrine,
honokiol, curcumin, oridonin and paeonol on leukemia cell lines.
Sichuan Da Xue Xue Bao Yi Xue Ban. 43:362–366. 2012.(In
Chinese).
|
|
19.
|
Wang G, Lemos JR and Iadecola C: Herbal
alkaloid tetrandrine: fron an ion channel blocker to inhibitor of
tumor proliferation. Trends Pharmacol Sci. 25:120–123. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Rao MR: Effects of tetrandrine on cardiac
and vascular remodeling. Acta Pharmacol Sin. 23:1075–1085.
2002.PubMed/NCBI
|
|
21.
|
Li X, Lu X, Xu H, et al:
Paclitaxel/tetrandrine coloaded nanoparticles effectively promote
the apoptosis of gastric cancer cells based on ‘oxidation therapy’.
Mol Pharm. 9:222–229. 2012.PubMed/NCBI
|
|
22.
|
Wu JM, Chen Y, Chen JC, Lin TY and Tseng
SH: Tetrandrine induces apoptosis and growth suppression of colon
cancer cells in mice. Cancer Lett. 287:187–195. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Liu B, Wang T, Qian X, Liu G, Yu L and
Ding Y: Anticancer effect of tetrandrine on primary cancer cells
isolated from ascites and pleural fluids. Cancer Lett. 268:166–175.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Chen YJ: Potential role of tetrandrine in
cancer therapy. Acta Pharmacol Sin. 23:1102–1106. 2002.PubMed/NCBI
|
|
25.
|
Ye Z, Sun A, Li L, Cao X and Ye W:
Reversal of adriamycin or vincristine resistance by tetrandrine in
human cancer cells in vitro. Zhongguo Zhong Yao Za Zhi. 21:369–371.
3841996.(In Chinese).
|
|
26.
|
Jin Q, Kang C, Soh Y, et al: Tetrandrine
cytotoxicity and its dual effect on oxidative stress-induced
apoptosis through modulating cellular redox states in Neuro 2a
mouse neuroblastoma cells. Life Sci. 71:2053–2066. 2002. View Article : Google Scholar
|
|
27.
|
Kuo PL and Lin CC: Tetrandrine-induced
cell cycle arrest and apoptosis in Hep G2 cells. Life Sci.
73:243–252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Cheng F, Li Y, Feng L and Li S: Effects of
tetrandrine on ischemia/reperfusion injury in mouse liver.
Transplant Proc. 40:2163–2166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Zhang P, Tang Iu N and Zhao YC: The
effects of Tetrandrine on the changes of IL-1beta, TNF-alpha and
IL-8 after cerebral ischemia/reperfusion in rats. Zhongguo Ying
Yong Sheng Li Xue Za Zhi. 22:443–444. 4782006.(In Chinese).
|
|
30.
|
Liu Z, Xu Z, Shen W, Li Y, Zhang J and Ye
X: Effect of pharmacologic preconditioning with tetrandrine on
subsequent ischemia/ reperfusion injury in rat liver. World J Surg.
28:620–624. 2004.PubMed/NCBI
|
|
31.
|
Chen Y, Chen JC and Tseng SH: Tetrandrine
suppresses tumor growth and angiogenesis of gliomas in rats. Int J
Cancer. 124:2260–2269. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Qian XP, Liu BR, Hu J, et al: Inhibitory
effect of tetrandrine on angiogenesis. Ai Zheng. 27:1050–1055.
2008.(In Chinese).
|
|
33.
|
Kobayashi S, Kimura I, Fukuta M, et al:
Inhibitory effects of tetrandrine and related synthetic compounds
on angiogenesis in streptozotocin-diabetic rodents. Biol Pharm
Bull. 22:360–365. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Kobayashi S, Inaba K, Kimura I and Kimura
M: Inhibitory effects of tetrandrine on angiogenesis in
adjuvant-induced chronic inflammation and tube formation of
vascular endothelial cells. Biol Pharm Bull. 21:346–349. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Liu C, Gong K, Mao X and Li W: Tetrandrine
induces apoptosis by activating reactive oxygen species and
repressing Akt activity in human hepatocellular carcinoma. Int J
Cancer. 129:1519–1531. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Chen XL, Ren KH, He HW and Shao RG:
Involvement of PI3K/ AKT/GSK3beta pathway in tetrandrine-induced G1
arrest and apoptosis. Cancer Biol Ther. 7:1073–1078. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Li X, Su B, Liu R, Wu D and He D:
Tetrandrine induces apoptosis and triggers caspase cascade in human
bladder cancer cells. J Surg Res. 166:e45–e51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Lu KW, Chen JC, Lai TY, et al: Gypenosides
suppress growth of human oral cancer SAS cells in vitro and in a
murine xenograft model: the role of apoptosis mediated by
caspase-dependent and caspase-independent pathways. Integr Cancer
Ther. 11:129–140. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Lu KW, Chen JC, Lai TY, et al: Gypenosides
causes DNA damage and inhibits expression of DNA repair genes of
human oral cancer SAS cells. In Vivo. 24:287–291. 2010.PubMed/NCBI
|
|
40.
|
Lu KW, Chen JC, Lai TY, et al: Gypenosides
inhibits migration and invasion of human oral cancer SAS cells
through the inhibition of matrix metalloproteinase-2 -9 and
urokinaseplasminogen by ERK1/2 and NF-kappa B signaling pathways.
Hum Exp Toxicol. 30:406–415. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Xie CM, Chan WY, Yu S, Zhao J and Cheng
CH: Bufalin induces autophagy-mediated cell death in human colon
cancer cells through reactive oxygen species generation and JNK
activation. Free Radic Biol Med. 51:1365–1375. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Vazquez CL and Colombo MI: Assays to
assess autophagy induction and fusion of autophagic vacuoles with a
degradative compartment, using monodansylcadaverine (MDC) and
DQ-BSA. Methods Enzymol. 452:85–95. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Chueh FS, Chen YL, Hsu SC, et al:
Triptolide induced DNA damage in A375.S2 human malignant melanoma
cells is mediated via reduction of DNA repair genes. Oncol Rep.
29:613–618. 2013.PubMed/NCBI
|
|
44.
|
Revonta M, Raitanen J, Sihvo S, et al:
Health and life style among infertile men and women. Sex Reprod
Healthc. 1:91–98. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Palefsky JM, Gillison ML and Strickler HD:
Chapter 16: HPV vaccines in immunocompromised women and men.
Vaccine. 24(Suppl 3): S3/140–146. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Gondi CS and Rao JS: Cathepsin B as a
cancer target. Expert Opin Ther Targets. 17:281–291. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Tekpli X, Holme JA, Sergent O and
Lagadic-Gossmann D: Role for membrane remodeling in cell death:
Implication for health and disease. Toxicology. 304:141–157. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Zhang XY, Xi XY and Zhao ZD: Autophagy
inhibitor 3-MA decreases the production and release of infectious
enterovirus 71 particles. Zhonghua Shi Yan He Lin Chuang Bing Du
Xue Za Zhi. 25:176–178. 2011.(In Chinese).
|
|
49.
|
Liu D, Yang Y, Liu Q and Wang J:
Inhibition of autophagy by 3-MA potentiates cisplatin-induced
apoptosis in esophageal squamous cell carcinoma cells. Med Oncol.
28:105–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
He Y, Zhao X, Gao J, et al: Quantum
dots-based immuno-fluorescent imaging of stromal fibroblasts
caveolin-1 and light chain 3b expression and identification of
their clinical significance in human gastric cancer. Int J Mol Sci.
13:13764–13780. 2012. View Article : Google Scholar
|
|
51.
|
Liu GH, Zhong Q, Ye YL, et al: Expression
of beclin 1 in bladder cancer and its clinical significance. Int J
Biol Markers. Nov 5–2012.(Epub ahead of print).
|
|
52.
|
Levy JM and Thorburn A: Targeting
autophagy during cancer therapy to improve clinical outcomes.
Pharmacol Ther. 131:130–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
Schrump DS: Cytotoxicity mediated by
histone deacetylase inhibitors in cancer cells: mechanisms and
potential clinical implications. Clin Cancer Res. 15:3947–3957.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Shen Y, Liang LZ, Hong MH, Xiong Y, Wei M
and Zhu XF: Expression and clinical significance of
microtubule-associated protein 1 light chain 3 (LC3) and Beclin1 in
epithelial ovarian cancer. Ai Zheng. 27:595–599. 2008.(In
Chinese).
|
|
55.
|
Pavlides S, Vera I, Gandara R, et al:
Warburg meets autophagy: cancer-associated fibroblasts accelerate
tumor growth and metastasis via oxidative stress, mitophagy, and
aerobic glycolysis. Antioxid Redox Signal. 16:1264–1284. 2012.
View Article : Google Scholar
|
|
56.
|
McLeland CB, Rodriguez J and Stern ST:
Autophagy monitoring assay: qualitative analysis of MAP LC3-I to II
conversion by immunoblot. Methods Mol Biol. 697:199–206. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
Reggiori F, Monastyrska I, Verheije MH, et
al: Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived
vesicles exporting short-lived ERAD regulators, for replication.
Cell Host Microbe. 7:500–508. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Gimenez-Xavier P, Francisco R, Platini F,
Perez R and Ambrosio S: LC3-I conversion to LC3-II does not
necessarily result in complete autophagy. Int J Mol Med.
22:781–785. 2008.PubMed/NCBI
|
|
59.
|
Cao Y, Nair U, Yasumura-Yorimitsu K and
Klionsky DJ: A multiple ATG gene knockout strain for yeast
two-hybrid analysis. Autophagy. 5:699–705. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
60.
|
Noda NN, Ohsumi Y and Inagaki F: ATG
systems from the protein structural point of view. Chem Rev.
109:1587–1598. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61.
|
Stasyk OV, Nazarko TY and Sibirny AA:
Methods of plate pexophagy monitoring and positive selection for
ATG gene cloning in yeasts. Methods Enzymol. 451:229–239. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
62.
|
Chung T, Suttangkakul A and Vierstra RD:
The ATG autophagic conjugation system in maize: ATG transcripts and
abundance of the ATG8-lipid adduct are regulated by development and
nutrient availability. Plant Physiol. 149:220–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
